Abstract
Background The presence of type 1 diabetes mellitus (T1DM) has been demonstrated to pose an increased risk for developing cardiovascular diseases (CVDs). However, the causal relationships between T1DM and CVDs remain unclear due to the uncontrolled confounding factors and reverse causation bias of the observational studies.
Aim To investigate the causal relationships between T1DM and seven major CVDs, including myocardial infarction (MI), heart failure (HF), coronary artery disease (CAD), atrial fibrillation (AF), coronary atherosclerosis, peripheral atherosclerosis, and stroke, using a two-sample bidirectional Mendelian randomization (MR) method.
Method We selected genetic instruments for T1DM and the seven CVDs from the largest available genome-wide association studies (GWAS) of European ancestry for the MR analysis. Three complementary methods: inverse variance weighted (IVW), weighted median, and MR-Egger were used for the MR estimates. The potential pleiotropic effects were assessed by MR-Egger intercept and MR-PRESSO global test. Additionally, multivariable MR (MVMR) analysis was performed to examine whether T1DM has independent effects on CVDs with adjustment of potential confounding factors. Moreover, a two-step MR approach was used to assess the potential mediating effects of these factors on the causal effects between T1DM and CVDs.
Results Causal effects of T1DM on peripheral atherosclerosis (odds ratio [OR]=1.06, 95% confidence interval [CI]: 1.02–1.10; p = 0.002)] and coronary atherosclerosis (OR=1.03, 95% CI: 1.01–1.05; p = 0.001) were found. The results were less likely to be biased by the horizontal pleiotropic effects (both p values of MR-Egger intercept and MR-PRESSO Global test > 0.05). In the following MVMR analysis, we found the causal effects of T1DM on peripheral atherosclerosis and coronary atherosclerosis remain significant after adjusting for a series of potential confounding factors. Moreover, we found that hypertension partly mediated the causal effects of T1DM on peripheral atherosclerosis (proportion of mediation effect in total effect: 11.47%, 95% CI: 3.23%–19.71%) and coronary atherosclerosis (16.84%, 95% CI: 5.35%–28.33%). We didn’t find significant causal relationships between T1DM and other CVDs, including MI, CAD, HF, AF, or stroke. For the reverse MR from CVD to T1DM, no significant causal relationships were identified.
Conclusion This MR study provided evidence supporting the causal effect of T1DM on peripheral atherosclerosis and coronary atherosclerosis, with hypertension partly mediating this effect.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The study was funded by the Suzhou Science and Technology Project (SKYD2022103) and Suzhou Specialized Program for Diagnosis and Treatment Techniques of Clinical Key Diseases (LCZX202103).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
As the necessary consent and ethics approvals were obtained for individual studies that contributed to this MR study, no additional consent or ethics approval was required specifically for the present study.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced are available online at https://gwas.mrcieu.ac.uk/
